Please cite this article in press as: Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res (2014), http://dx. doi. org/10. 1016/j. bbr. 2014. 07. 016ARTICLE IN PRESSG Model BBR 9035 1-22 18 A. L. Halberstadt / Behavioural Brain Research xxx (2014) xxx-xxx [209] Callaway CW, Wing LL, Geyer MA. Serotonin release contributes to the loco-motor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 1990;254:456-64. [210] Lehmann-Masten VD, Geyer MA. Spatial and temporal patterning distin-guishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology 1991;30:629-36. [211] Adams LM, Geyer MA. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide. Pharmacol Biochem Behav 1985;23:461-8. [212] Krebs-Thomson K, Paulus MP, Geyer MA. Effects of hallucinogens on locomo-tor and investigatory activity and patterns: inﬂuence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 1998;18:339-51. [213] Mittman SM, Geyer MA. Disassociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharma-cology (Berl) 1991;105:69-76. [214] Krebs-Thomson K, Geyer MA. The role of 5-HT1A receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT and LSD in rats. Behav Pharmacol 1996;7:551-9. [215] Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. Modiﬁcation of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behav-ior in rats by monoamine oxidase inhibitors. Psychopharmacology (Berl) 2008;201:55-66. [216] Tanaka S, Young JW, Halberstadt AL, Masten VL, Geyer MA. Four factors under-lying mouse behavior in an open ﬁeld. Behav Brain Res 2012;233:55-61. [217] Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, et al. 5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 2009;34:1958-67. [218] Halberstadt AL, Powell SB, Geyer MA. Role of the 5-HT 2Areceptor in the loco-motor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology 2013;70:218-27. [219] Darmani NA, Shaddy J, Gerdes CF. Differential ontogenesis of three DOI-induced behaviors in mice. Physiol Behav 1996;60:1495-500. [220] Brookshire BR, Jones SR. Direct and indirect 5-HT receptor agonists produce gender-speciﬁc effects on locomotor and vertical activities in C57 BL/6J mice. Pharmacol Biochem Behav 2009;94:194-203. [221] Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, et al. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors'. J Neural Transm 2011;118:1511-22. [222] Van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-Me O-DMT, on locomotor activity in 5-HT 1Areceptor knockout mice: impli-cations for schizophrenia. Neuropharmacology 2011;61:209-16. [223] Leysen JE, Janssen PF, Niemegeers CJ. Rapid desensitization and down-regulation of 5-HT 2receptors by DOM treatment. Eur J Pharmacol 1989;163:145-9. [224] Buckholtz NS, Zhou DF, Freedman DX. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors. Life Sci 1989;42:2439-45. [225] Buckholtz NS, Zhou DF, Freedman DX, Potter WZ. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology 1990;3:137-48. [226] Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology 2005;30:1693-702. [227] Gillin JC, Kaplan J, Stillman R, Wyatt RJ. The psychedelic model of schizophre-nia: the case of N,N-dimethyltryptamine. Am J Psychiatry 1976;133:203-8. [228] Strassman RJ, Qualls CR, Berg LM. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry 1996;39:784-95. [229] Roth BL, Palvimaki EP, Berry S, Khan N, Sachs N, Uluer A, et al. 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J Pharmacol Exp Ther 1995;275:1638-46. [230] Singewald N, Philippu A. Release of transmitters in the locus coeruleus. Prog Neurobiol 1998;56:237-67. [231] Aghajanian GK. Mescaline and LSD facilitate the activation of locs coeruleus neurons by peripheral stimuli. Brain Res 1980;186:492-8. [232] Rasmussen K, Aghajanian GK. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT 2antagonists. Brain Res 1986;385:395-400. [233] Gorea E, Adrien J. Serotonergic regulation of noradrenergic coerulean neu-rons: electrophysiological evidence for the involvement of 5-HT 2receptors. Eur J Pharmacol 1988;154:285-91. [234] Chiang C, Aston-Jones G. A 5-hydroxytryptamine 2agonist augments /H9253-aminobutyric acid and excitatory amino acid inputs into noradrenergic locus coeruleus neurons. Neuroscience 1993;54:409-20. [235] Done J, Sharp T. Evidence that 5-HT2 receptor activation decreases nora-drenaline release in rat hippocampus in vivo. Br J Pharmacol 1992;107: 240-5. [236] Szabo ST, Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the ﬁring activity of locus coeruleus nore-pinephrine neurons. Brain Res 2001;922:9-20. [237] Cornea-Hébert V, Riad M, Wu C, Singh SK, Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 1999;409:187-209. [238] Gorea E, Davenne D, Lanfumey L, Chastanei M, Adrien J. Regulation of noradrenergic coerulean neuronal ﬁring mediated by 5-HT 2receptor: involvement of the prepositus hypoglossil nucleus. Neuropharmacology 1991;30:1309-18. [239] Ennis M, Aston-Jones G. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J Neurosci 1989;9:2973-81. [240] Ennis M, Aston-Jones G. Potent inhibitory input to locus coeruleus from the nucleus prepositus hypoglossi. Brain Res Bull 1989;22:793-803. [241] Bobker DH. A slow excitatory postsynaptic potential mediated by 5-HT 2 receptors in nucleus prepositus hypoglossi. J Neurosci 1994;14:2428-34. [242] Ennis M, Aston-Jones G. A potent excitatory input to the nucleus locus coeruleus from the ventrolateral medulla. Neurosci Lett 1986;71:299-305. [243] Rasmussen K, Aghajanian GK. Failure to block responses of locus coeruleus neurons to somatosensory stimuli by destruction of two major afferent nuclei. Synapse 1989;4:162-4. [244] Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989;290:213-42. [245] Jodo E, Aston-Jones G. Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs. Brain Res 1997;768:327-32. [246] Jodo E, Aston-Jones G. Potent excitatory inﬂuence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 1998;83:63-79. [247] Palacios JM, Hoyer D, Cortes R. /H92511-Adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents primates. Brain Res 1987;419:65-75. [248] Marek GJ, Aghajanian GK. 5-HT 2Areceptor or /H92511-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 1999;367:197-206. [249] Geyer MA, Gordon J, Adams LM. Behavioral effects of xylamine-induced depletions of brain norepinephrine: interaction with LSD. Pharmacol Biochem Behav 1985;23:619-25. [250] Mengod G, Pompeiano M, Martínez-Mir MI, Palacios JM. Localization of the m RNA for the 5-HT2 receptor by in situ hybridization histochemistry Corre-lation with the distribution of receptor sites. Brain Res 1990;524:139-43. [251] López-Giménez JF, Mengod G, Palacios JM, Vilaró MT. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn-Schmiedeberg's Arch Pharmacol 1997;356:446-54. [252] Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine 2Aserotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A 1998;95:735-40. [253] De Almeida J, Mengod G. Quantitative analysis of glutamatergic and GABAer-gic neurons expressing 5-HT 2Areceptors in human and monkey prefrontal cortex. J Neurochem 2007;103:475-86. [254] Amargós-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, et al. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 2004;14:281-99. [255] Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of sero-tonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2004;14:1100-9. [256] Willins DL, Deutch AY, Roth BL. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 1997;27:79-82. [257] Xu T, Pandey SC. Cellular localization of serotonin 2A(5HT 2A) receptors in the rat brain. Brain Res Bull 2000;51:499-505. [258] Jakab RL, Goldman-Rakic PS. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 2000;417:337-48. [259] Puig MV, Watakabe A, Ushimaru M, Yamamori T, Kawaguchi Y. Sero-tonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J Neurosci 2010;30:2211-22. [260] Weber ET, Andrade R. Htr2a gene and 5-HT 2Areceptor expression in the cerebral cortex studied using genetically modiﬁed mice. Front Neurosci 2010;4(pii):36. [261] Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscil-lations in inhibitory interneuron networks. Nat Rev Neurosci 2007;8:45-56. [262] Freund TF, Katona I. Perisomatic inhibition. Neuron 2007;56:33-42. [263] Buzsaki G, Wang XJ. Mechanisms of gamma oscillations. Ann Rev Neurosci 2012;35:203-25. [264] Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat asso-ciation cortex. Neuroscience 1991;40:399-412. [265] Tanaka E, North RA. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 1993;69:1749-57. [266] Arvanov VL, Liang X, Magro P, Roberts R, Wang RY. A pre- and postsynap-tic modulatory action of 5-HT and the 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Eur J Neurosci 1999;11:2917-34. [267] Villalobos C, Beique JC, Gingrich JA, Andrade R. Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex. Eur J Neu-rosci 2005;22:1120-6. [268] Villalobos C, Foehring RC, Lee JC, Andrade R. Essential role for phos-phatidylinositol 4,5-bisphosphate in the expression, regulation, and gating of the slow afterhyperpolarization current in the cerebral cortex. J Neurosci 2011;31:18303-12. [269] Zhang ZW, Arsenault D. Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex. J Physiol 2005;566(Pt 2):379-94. [270] Carr DB, Cooper DC, Ulrich SL, Spruston N, Surmeier DJ. Serotonin receptor activation inhibits sodium current and dendritic excitability in1869 18701871187218731874187518761877187818791880188118821883188418851886188718881889189018911892189318941895189618971898189919001901190219031904190519061907190819091910191119121913191419151916191719181919192019211922192319241925192619271928192919301931193219331934193519361937193819391940194119421943194419451946194719481949195019511952195319541955 1956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031203220332034203520362037203820392040